1 |
Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case LE, et al. Pompe disease diagnosis and management guideline. Genet Med 2006;8:267-88.
DOI
|
2 |
Labrousse P, Chien YH, Pomponio RJ, Keutzer J, Lee NC, Akmaev VR, et al. Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program. Mol Genet Metab 2010;99:379-83.
DOI
|
3 |
Kroos M, Pomponio RJ, van Vliet L, Palmer RE, Phipps M, Van der Helm R, et al. Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating. Hum Mutat 2008;29:E13-26.
DOI
|
4 |
Kim MS, Song A, Im M, Huh J, Kang IS, Song J, et al. Clinical and molecular characterization of Korean children with infantile and late-onset Pompe disease: 10 years of experience with enzyme replacement therapy at a single center. Korean J Pediatr 2019;62:224-34.
DOI
|
5 |
Sawada T, Kido J, Nakamura K. Newborn screening for pompe disease. Int J Neonatal Screen 2020;6:31.
|
6 |
Sawada T, Kido J, Sugawara K, Momosaki K, Yoshida S, Kojima-Ishii K, et al. Current status of newborn screening for Pompe disease in Japan. Orphanet J Rare Dis 2021;16:516.
|
7 |
Chien YH, Hwu WL, Lee NC. Newborn screening: Taiwanese experience. Ann Transl Med 2019;7:281.
|
8 |
Klug TL, Swarts LB, Washburn J, Brannen C, Kiesling JL. Lessons learned from pompe disease newborn screening and follow-up. Int J Neonatal Screen 2020;6:11.
|
9 |
Park KS. Carrier frequency and predicted genetic prevalence of Pompe disease based on a general population database. Mol Genet Metab Rep 2021;27:100734.
|
10 |
Chien YH, Lee NC, Huang HJ, Thurberg BL, Tsai FJ, Hwu WL. Later onset Pompe disease: early detection and early treatment initiation enabled by newborn screening. J Pediatr 2011;158:1023-7.
DOI
|